Shopping Cart
Remove All
Your shopping cart is currently empty
A2AAR antagonist 4 is an orally active antagonist of the A2A adenosine receptor (A2AAR) with a Ki value of 0.36 nM and a KB value of 1 nM in humans. At a concentration of 10 μM, it fully inhibits both human A2AAR and human A2bAR. A2AAR antagonist 4 is applicable in cancer research, such as studies involving MC38 tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | A2AAR antagonist 4 is an orally active antagonist of the A2A adenosine receptor (A2AAR) with a Ki value of 0.36 nM and a KB value of 1 nM in humans. At a concentration of 10 μM, it fully inhibits both human A2AAR and human A2bAR. A2AAR antagonist 4 is applicable in cancer research, such as studies involving MC38 tumors. |
| Targets&IC50 | A2B (human):85.8 nM (Ki) |
| In vitro | A2AAR antagonist 4 (Compound 4d) at a concentration of 10 μM completely inhibits hA2A AR, hA2B AR, and hA3 AR in the CHO-A2A cell line. Additionally, A2AAR antagonist 4, within the range of 0.1-1000 nM, restores IL-2 secretion in PBMC cells by fully displacing NECA, with an EC50 value of 2.06 nM. |
| In vivo | Compound 4d, an A2AAR antagonist, significantly inhibits tumor growth in MC38 tumor-bearing mice when administered at 100 mg/kg orally or 50 mg/kg via intraperitoneal injection, twice daily for 14 days. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.